Home › Funds › GLAZER CAPITAL, LLC › DMII

GLAZER CAPITAL, LLC position in DMII

DRUGS MADE IN AMERICA ACQUISITION II CORP · Financials

GLAZER CAPITAL, LLC reported holding 2,343,278 shares of DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP) in its Q2 2026 13F filing — a position valued at US$23.6M, representing 0.70% of its reported portfolio and ranking #21 among its reported holdings. GLAZER CAPITAL, LLC has disclosed DMII holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)2.34M sh
Reported value held$23.57M
Portfolio Weight0.70%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GLAZER CAPITAL, LLC's DMII position evolved

GLAZER CAPITAL, LLC first disclosed a stake in DMII in Q4 2025 at 2,349,899 shares (US$23.3M). The position peaked in Q2 2026 at 2,343,278 shares, worth US$23.6M. Across 3 filings, GLAZER CAPITAL, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 2,343,278 shares valued at US$23.6M.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.35M $23.26M New
Q1 2026 2.35M $23.43M Hold
Q2 2026 2.34M $23.57M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DMII and 13F data

DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP) is a Financials company. 70 other funds we track also report a position in DMII — the largest reported positions include Karpus Management, Inc. (US$28.0M), Magnetar Financial LLC (US$27.2M), MMCAP International Inc. SPC (US$27.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DMII

All DMII fund holders →

FAQ

How long has GLAZER CAPITAL, LLC held DMII?

GLAZER CAPITAL, LLC has disclosed DMII holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is GLAZER CAPITAL, LLC's current position in DMII?

As of Q2 2026, GLAZER CAPITAL, LLC holds 2.34M shares of DMII (DRUGS MADE IN AMERICA ACQUISITION II CORP), valued at $23.57M, representing 0.70% of its reported portfolio and ranking #21.

Has GLAZER CAPITAL, LLC been buying or selling DMII?

In the latest 13F filing (Q2 2026), GLAZER CAPITAL, LLC held unchanged its position in DMII. The position peaked in Q2 2026 at 2.34M shares.

Which other funds hold DMII?

Other major institutional holders of DMII include Karpus Management, Inc., Magnetar Financial LLC, MMCAP International Inc. SPC, among 70 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.